https://scholars.lib.ntu.edu.tw/handle/123456789/465821
標題: | A blind, randomized comparison of racecadotril and loperamide for stopping acute diarrhea in adults | 作者: | Wang H.-H. MING-JIUM SHIEH Liao K.-F. |
關鍵字: | Acute diarrhea; Loperamide; Racecadotril | 公開日期: | 2005 | 出版社: | WJG Press | 卷: | 11 | 期: | 10 | 起(迄)頁: | 1540-1543 | 來源出版物: | World Journal of Gastroenterology | 摘要: | Aim: Racecadotril is a specific enkephalinase inhibitor that exhibits intestinal antisecretory activity without affecting intestinal transit. Loperamide is an effective anti-diarrheal agent, but it usually induces constipation. This study is to compare the efficacy, safety, and tolerability of racecadotril versus loperamide in the outpatient treatment of acute diarrhea in adults. Methods: A two-center, randomized, parallel-group, single-blind study was carried out to compare the efficacy, tolerability, and safety of racecadotril (100 mg thrics daily) and loperamide (2.0 mg 2 twics daily) in 62 adult patients suffering from acute diarrhea. The main efficacy criterion used was the duration of diarrhea after beginning the treatment (in hours). Other signs and symptoms were also evaluated. Results: The clinical success rates for these anti-diarrheal treatments were 95.7% and 92.0% for racecadotril and loperamide respectively. Patients on racecadotril had a median duration of diarrhea of 19.5 h compared with a median of 13 h for patients on loperamide. Rapid improvement in anal burn and nausea was found for each drug. However, more patients on loperamide suffered from reactive constipation (29.0% vs 12.9%). Itching, another adverse event was notably higher in the racecadotril group (28.6% vs 0%). With regard to other adverse events, the two medications showed similar occurrence rates and similar concomitant medication usage rates. Conclusion: Racecadotril and loperamide are rapid, equally effective treatments for acute diarrhea in adults, but loperamide treatment is associated with a higher incidence of treatment-related constipation. ? 2005 The WJG Press and Elsevier Inc. All rights reserved. |
URI: | https://www.scopus.com/inward/record.uri?eid=2-s2.0-16344362645&doi=10.3748%2fwjg.v11.i10.1540&partnerID=40&md5=9db9cae6c6a3254d0004b98cfc85dc26 https://scholars.lib.ntu.edu.tw/handle/123456789/465821 |
ISSN: | 1007-9327 | DOI: | 10.3748/wjg.v11.i10.1540 | SDG/關鍵字: | acetorphan; antidiarrheal agent; enkephalinase inhibitor; loperamide; membrane metalloendopeptidase; abdominal pain; acute diarrhea; adult; article; clinical trial; constipation; controlled clinical trial; controlled study; disease control; disease duration; drug dose regimen; drug efficacy; drug mechanism; drug safety; drug tolerability; female; human; intestine function; intestine transit time; major clinical study; male; multicenter study; nausea; outpatient care; pruritus; randomized controlled trial; single blind procedure; treatment outcome |
顯示於: | 醫學工程學研究所 |
在 IR 系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。